Linde A. Miles

3.2k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Linde A. Miles is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Linde A. Miles has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Genetics. Recurrent topics in Linde A. Miles's work include Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Single-cell and spatial transcriptomics (3 papers). Linde A. Miles is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Single-cell and spatial transcriptomics (3 papers). Linde A. Miles collaborates with scholars based in United States, New Zealand and Germany. Linde A. Miles's co-authors include John T. Poirier, Megan L. Matthews, Carsten Krebs, J. Martin Bollinger, Charles M. Rudin, Elisa de Stanchina, Eric E. Gardner, Squire J. Booker, Christopher T. Walsh and Christopher S. Neumann and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Linde A. Miles

18 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TMEM41B Is a Pan-flavivirus Host Factor

2020 136 citations Hans-Heinrich Hoffmann, William M. Schneider et al. Cell profile →

Peers

Linde A. Miles

ONCOL

PFM

Zanna Beharry United States

Per Arne Norway

Laurie E. Grove United States

Ganesh Nagaraju India

Kentaro Yoshimatsu Japan

Susan P. Grill United States

Axel‐R. Hanauske Germany

Dominik A. Megger Germany

Cy A. Stein United States

Caroline Clairmont United States

Zanna Beharry United States

Linde A. Miles

736 ×0.9

279 ×0.5

ONCOL

80 ×0.3

175 ×1.0

399 ×2.5

PFM

Citations per year, relative to Linde A. Miles Linde A. Miles (= 1×) peers Zanna Beharry

Countries citing papers authored by Linde A. Miles

Since Specialization

Citations

This map shows the geographic impact of Linde A. Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linde A. Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linde A. Miles more than expected).

Fields of papers citing papers by Linde A. Miles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linde A. Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linde A. Miles. The network helps show where Linde A. Miles may publish in the future.

Co-authorship network of co-authors of Linde A. Miles

This figure shows the co-authorship network connecting the top 25 collaborators of Linde A. Miles. A scholar is included among the top collaborators of Linde A. Miles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linde A. Miles. Linde A. Miles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Schwede, Matthew, Katharina Jahn, Jack Kuipers, et al.. (2024). Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Leukemia. 38(7). 1501–1510. 10 indexed citations

Robinson, Troy M., Robert L. Bowman, Ying Liu, et al.. (2023). Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia. Science Advances. 9(38). eadg0488–eadg0488. 24 indexed citations

Li, Jingjing, et al.. (2023). Chronic inflammation can transform the fate of normal and mutant hematopoietic stem cells. Experimental Hematology. 127. 8–13. 8 indexed citations

Okabe, Rachel, Alexandra Schurer, Meng Tong, et al.. (2022). Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical Cancer Research. 29(5). 943–956. 1 indexed citations

Eudy, Elizabeth, Matthew A. Loberg, Linde A. Miles, et al.. (2022). Cell origin–dependent cooperativity of mutant Dnmt3a and Npm1 in clonal hematopoiesis and myeloid malignancy. Blood Advances. 6(12). 3666–3677. 13 indexed citations

Miles, Linde A., Laura N. Burga, Charles M. Rudin, et al.. (2021). N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus Infection. Viruses. 13(5). 769–769. 7 indexed citations

Azzopardi, Stephanie A., Linde A. Miles, William M. Schneider, et al.. (2021). A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry. Viruses. 13(11). 2113–2113. 13 indexed citations

Xiao, Wenbin, Linde A. Miles, Robert L. Bowman, et al.. (2020). A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN. Blood Advances. 4(23). 6034–6038. 2 indexed citations

Hoffmann, Hans-Heinrich, William M. Schneider, Kathryn Rozen-Gagnon, et al.. (2020). TMEM41B Is a Pan-flavivirus Host Factor. Cell. 184(1). 133–148.e20. 136 indexed citations breakdown →

10.

Loberg, Matthew A., Rebecca K. Bell, Leslie O. Goodwin, et al.. (2019). Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Leukemia. 33(7). 1635–1649. 77 indexed citations

11.

Miles, Linde A., Robert L. Bowman, Aik T. Ooi, et al.. (2019). Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies. Blood. 134(Supplement_1). 913–913. 1 indexed citations

12.

Gardner, Eric E., Benjamin H. Lok, Valentina E. Schneeberger, et al.. (2017). Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. Cancer Cell. 31(2). 286–299. 347 indexed citations

13.

Yao, Zhan, Rona Yaeger, Vanessa Rodrik-Outmezguine, et al.. (2017). Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS. Nature. 548(7666). 234–238. 349 indexed citations

14.

Miles, Linde A., Laura N. Burga, Eric E. Gardner, et al.. (2017). Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus. Journal of Clinical Investigation. 127(8). 2957–2967. 60 indexed citations

15.

Miles, Linde A., Ralph Garippa, & John T. Poirier. (2016). Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens. FEBS Journal. 283(17). 3170–3180. 54 indexed citations

16.

Miles, Linde A., W. Nathaniel Brennen, Charles M. Rudin, & John T. Poirier. (2015). Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy. PLoS ONE. 10(6). e0129103–e0129103. 7 indexed citations

17.

Matthews, Megan L., et al.. (2014). Direct nitration and azidation of aliphatic carbons by an iron-dependent halogenase. Nature Chemical Biology. 10(3). 209–215. 137 indexed citations

18.

Matthews, Megan L., Christopher S. Neumann, Linde A. Miles, et al.. (2009). Substrate positioning controls the partition between halogenation and hydroxylation in the aliphatic halogenase, SyrB2. Proceedings of the National Academy of Sciences. 106(42). 17723–17728. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact